Currently browsing tag

said-on-tuesday

Double joy as mother of only giant panda twins in U.S. pregnant again

By David Beasley ATLANTA (Reuters) – The mother of the only giant panda twins in the United States may soon deliver a second set of twins, Zoo Atlanta said on Tuesday, capping off an eventful month for lovers of the fluffy black and white bears across the globe. Three years ago, mother bear Lun Lun gave birth to female cubs Mei Lun and Mei Huan, who are still at the Georgia zoo but could be returned this fall to China, which owns them, zoo spokeswoman Rachel Davis said. An ultrasound on Monday confirmed that Lun Lun, who turns 19 years old on Thursday, is once again pregnant with twins, the zoo said.

Chinese guide stabs, kills tourist in Kenya’s Maasai Mara

A Chinese tour guide stabbed and killed a tourist who was visiting Kenya's famed Maasai Mara Game Reserve after an argument over the seating arrangement for dinner, police and a lodge manager said on Tuesday. John Kiruti, manager of Keekorok Lodge, which is within the park, said the woman, also a Chinese citizen, sustained serious chest injuries in the incident late on Monday and died as she was being transferred to another tourist camp for treatment. “The tour guide who had brought three clients from his country for two nights differed with the couple … over the sitting arrangement at dinner time,” Kiruti said.

Anthem CEO expects U.S. regulatory decision in July

By Caroline Humer NEW YORK (Reuters) – Anthem Inc Chief Executive Officer Joseph Swedish said on Tuesday the health insurer was pushing for approval from antitrust regulators reviewing its $51 billion acquisition of Cigna Corp and expects to hear a decision in July. Anthem's bid for Cigna followed closely after Aetna Inc's proposed $34 billion purchase of Humana Inc last July. Swedish said antitrust regulators have asked many questions about how it and Cigna manage healthcare benefits for large employers, but that the overall review was moving forward as expected.

Europeans spend 24 billion euros on narcotics each year: report

European Union citizens spend some 24 billion euros ($27.28 billion) on illicit drugs every year, a report said on Tuesday, making it one of the continent’s most profitable activities for organized crime groups. The report, drawn up by Europol and European Union drugs monitoring center EMCDDA, said the advent of new technology such as encrypted networks and digital currencies had opened a new market for the online supply of drugs. “Illicit drug production and trafficking remains one of the largest and most innovative criminal markets in Europe,” Europol director Rob Wainwright said in a statement.

P&G stops selling Vicks Action 500 Extra in India after ban

U.S. consumer health giant Procter & Gamble’s India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk. The product is a fixed dose combination of paracetamol, phenylephrine and caffeine, which was banned by India’s health ministry in a notice issued over the weekend, Procter & Gamble Hygiene and Health Care Ltd informed the stock exchange. The drug was one of 344 drug combinations including several antibiotics and analgesics that India ordered to be prohibited saying a government-appointed panel of experts had found the combinations lacked “therapeutic justification.” P&G said all its products, including Vicks Action 500 Extra, were backed by research to support their quality, safety and efficacy.

Paraguay could face threat from dengue, other fevers this year

Paraguay could face problems this year with dengue and other fevers transmitted by mosquitoes, which have proliferated due to rainy weather during the Southern Hemisphere summer, a health ministry official said on Tuesday. Paraguay had a record 150,000 dengue infections and 262 deaths in 2013. Concern this year extends to zika and chikungunya fevers, Paraguay’s director of preventive health, Águeda Cabello, told Reuters.

South Korea conducts experimental plasma therapy on MERS patients

By Jack Kim SEOUL (Reuters) – Two South Korean hospitals are conducting experimental treatment on Middle East Respiratory Syndrome (MERS) patients, injecting them with blood plasma from recovering patients, the health ministry said on Tuesday, as four new cases were reported. The procedure has been conducted on two consenting MERS patients in addition to existing care, the ministry's head of public health policy, Kwon Jun-wook, told a media briefing. “There is insufficient clinical basis about the result of plasma treatment among experts in the country,” Kwon said, but added: “The ministry has deep confidence in the medical staff on the direction of the treatment.” Plasma treatment was previously used in SARS patients with some positive results in seriously ill patients that led to a decrease in the death rate by up to 23 percent, Kwon said.

Ebola volunteers should be praised, not stigmatized: UK charities

By Liisa Tuhkanen LONDON (Thomson Reuters Foundation) – Volunteer medics returning to Britain after fighting the Ebola outbreak in West Africa face unfounded stigma that can be made worse by official safety guidelines, charities said on Tuesday. “These people are putting their lives at risk and instead of being appreciated many of them are facing unfounded stigma on their return,” said Sarah Wilson, communication manager for Ebola response at World Vision. “They should be lauded when they come back home… not discouraged from volunteering. …